Fujian Wanchen Biotechnology Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Other Agricultural Products
  • ISIN: CNE100004KH1
CNY
181.69
-0.74 (-0.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
32,265.41
9,272.77
545.98
431.62
447.13
448.13
340.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
32,265.41
9,272.77
545.98
431.62
447.13
448.13
340.26
Raw Material Cost
29,002.83
8,492.39
465.02
392.96
327.50
321.46
276.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
611.27
113.70
85.64
74.99
73.42
63.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
53.34
31.01
4.39
5.24
7.63
14.06
12.43
Selling and Distribution Expenses
2,265.47
822.73
49.28
22.87
19.69
21.51
19.39
Other Expenses
-5.08
-63.99
-11.61
-8.89
-8.22
-8.73
-7.54
Total Expenditure (Excl Depreciation)
31,270.87
9,317.55
516.24
417.82
347.62
343.15
295.60
Operating Profit (PBDIT) excl Other Income
994.5
-44.800000000000004
29.700000000000003
13.799999999999999
99.5
105
44.699999999999996
Other Income
103.15
-1.63
16.35
21.70
4.30
2.42
2.60
Operating Profit (PBDIT)
1,366.95
139.21
111.56
95.69
163.42
166.74
97.47
Interest
53.34
31.01
4.39
5.24
7.63
14.06
12.43
Exceptional Items
0.00
-0.81
-0.11
-0.07
-0.05
-0.62
-0.03
Gross Profit (PBDT)
3,262.58
780.38
80.96
38.66
119.63
126.67
64.05
Depreciation
281.17
192.10
65.48
61.32
59.61
59.88
50.27
Profit Before Tax
1,032.44
-84.72
41.58
29.06
96.13
92.19
34.74
Tax
429.18
61.30
0.04
5.61
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
293.52
-82.93
47.74
23.45
96.13
92.19
34.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
293.52
-82.93
47.74
23.45
96.13
92.19
34.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
309.74
-63.10
-6.20
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
603.26
-146.02
41.54
23.45
96.13
92.19
34.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,098.15
645.36
668.15
652.71
400.65
344.82
333.22
Earnings per share (EPS)
1.57
-0.54
0.31
0.15
0.63
0.6
0.23
Diluted Earnings per share
1.57
-0.54
0.31
0.15
0.63
0.6
0.23
Operating Profit Margin (Excl OI)
3.05%
-0.55%
5.45%
2.94%
22.26%
23.31%
13.11%
Gross Profit Margin
4.07%
1.16%
19.61%
20.94%
34.83%
33.93%
24.98%
PAT Margin
0.91%
-0.89%
8.74%
5.43%
21.5%
20.57%
10.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 247.96% vs 1,598.32% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 513.22% vs -451.81% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 797.59% vs 47.90% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 71.94% vs 604.55% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Fujian Wanchen Biotechnology Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
32,265.41
0
32,265.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
32,265.41
0
32,265.41
Raw Material Cost
29,002.83
0
29,002.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
53.34
0
53.34
Selling and Distribution Expenses
2,265.47
0
2,265.47
Other Expenses
-5.08
0.00
-5.08
Total Expenditure (Excl Depreciation)
31,270.87
0
31,270.87
Operating Profit (PBDIT) excl Other Income
994.54
0.00
994.54
Other Income
103.15
0
103.15
Operating Profit (PBDIT)
1,366.95
0
1,366.95
Interest
53.34
0
53.34
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
3,262.58
0
3,262.58
Depreciation
281.17
0
281.17
Profit Before Tax
1,032.44
0
1,032.44
Tax
429.18
0
429.18
Provisions and contingencies
0
0
0.00
Profit After Tax
293.52
0
293.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
293.52
0
293.52
Share in Profit of Associates
0
0
0.00
Minority Interest
309.74
0
309.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
603.26
0
603.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,098.15
0
1,098.15
Earnings per share (EPS)
1.57
0
1.57
Diluted Earnings per share
1.57
0
1.57
Operating Profit Margin (Excl OI)
3.05%
0%
0.00
3.05%
Gross Profit Margin
4.07%
0%
0.00
4.07%
PAT Margin
0.91%
0%
0.00
0.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3,226.54 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 247.96% vs 1,598.32% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 60.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 513.22% vs -451.81% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 126.38 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 797.59% vs 47.90% in Dec 2023

Annual - Interest
Interest 5.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 71.94% vs 604.55% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.05%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023